Knopp Biosciences expands research collaboration with Cincinnati Children’s
Knopp Biosciences announced the expansion of its research collaboration with Cincinnati Children’s Hospital Medical Center to further elucidate the eosinophil-depleting mechanism of action of Knopp’s lead investigational drug, dexpramipexole. January 16, 2019